top of page

Domestic:

+91 92 5656 7676 

International:

+1 647 893 7323 

How to Start a Pharma Manufacturing Unit in India

India is one of the largest providers of generic medicines globally, and the Indian pharmaceutical industry has become a global force known for cost-effective and high-quality production. The country ranks third in terms of pharmaceutical production by volume and fourteenth by value. With favorable government policies, an expanding market, and global demand, starting a pharmaceutical manufacturing unit in India is a lucrative and rewarding venture.


This article provides a comprehensive guide on how to start a pharma manufacturing unit in India — covering legal procedures, documentation, infrastructure, investments, and more.


1. Understanding the Pharma Market in India

India's pharmaceutical industry is expected to grow to USD 130 billion by 2030 (Source: Invest India). This surge is driven by:

  • Rising healthcare needs

  • Growing middle-class population

  • Expanding insurance coverage

  • Government schemes like Ayushman Bharat and Production Linked Incentive (PLI) scheme

Understanding these market dynamics will help you choose the right segment: allopathic, ayurvedic, herbal, nutraceuticals, veterinary, or biopharma.


2. Decide on the Type of Manufacturing

The pharmaceutical sector allows you to choose from the following types of manufacturing setups:

  • Formulations (Finished Dosage Forms): Tablets, Capsules, Syrups, Injectables, Ointments

  • Bulk Drugs / APIs (Active Pharmaceutical Ingredients)

  • Ayurvedic and Herbal Products

  • Nutraceuticals / Dietary Supplements

  • Cosmeceuticals

  • Contract / Third-Party Manufacturing Unit

Choose based on your investment capacity, target market, and technical expertise.


3. Key Requirements to Start a Pharma Manufacturing Unit

Before diving into the licensing and paperwork, you must ensure the following are in place:

a. Infrastructure Requirements

  • Land & Building: Minimum space of 1000 to 3000 sq. ft., depending on the product range

  • Location: Preferably in an industrial zone with pollution clearance

  • Design: As per Schedule M (Good Manufacturing Practices - GMP) norms

  • Utilities: Water supply, HVAC (Heating, Ventilation & Air Conditioning), Power backup, Effluent Treatment

b. Technical Staff

As per Drug and Cosmetics Act, 1940, minimum staff requirements include:

  • Production Head: B. Pharm/M. Pharm with experience

  • Quality Control Analyst: Science graduate with chemistry background

  • Microbiologist: For sterile or sensitive products


4. Licenses and Approvals Required

Here is a step-by-step breakdown of regulatory approvals needed:

a. Company Registration

Register your business as one of the following entities:

  • Proprietorship

  • Partnership

  • LLP (Limited Liability Partnership)

  • Pvt. Ltd. Company (preferred for pharma)

Register with Ministry of Corporate Affairs (MCA) and get a CIN (Corporate Identification Number).

b. Drug Manufacturing License

Obtain from the State Drug Control Department:

  • Form 25: For allopathic drugs (non-schedule C & C1)

  • Form 28: For Schedule C & C1 drugs (injections, vaccines)

  • Form 32: For Ayurvedic medicines

  • Form 25-D: For cosmetics

Prerequisites:

  • Premises and layout plan approval

  • Plant and machinery setup

  • Technical staff details

  • Product list and formulation

  • GMP-compliance infrastructure

c. GMP & WHO Certification

Mandatory for local, and especially export-oriented units.

  • GMP (Good Manufacturing Practices): From CDSCO or State FDCA

  • WHO-GMP Certification: For credibility in international markets

d. Environmental Clearance

For effluent discharge and air pollution control from State Pollution Control Board (SPCB)

e. Factory License

Under Factories Act, 1948, from Chief Inspector of Factories

f. Fire Safety Certificate

From local fire department

g. Trademark & FSSAI (if applicable)

  • Trademark: For brand protection

  • FSSAI: If manufacturing nutraceuticals or food-based products


5. Documentation Checklist

You’ll need the following documents for a pharma manufacturing unit:

  1. Company registration certificate

  2. Site master file and layout plan

  3. Detailed project report

  4. Affidavit for non-conviction of directors

  5. List of machinery and equipment

  6. Copies of qualification and experience of staff

  7. Product list and formulations

  8. Ownership/rent agreement for premises

  9. Pollution NOC

  10. GMP certificate (if available)


6. Investment Required

The total cost depends on the product type and scale. Here’s a basic estimate:

Type

Estimated Investment

Small-scale (general tablets, capsules)

₹30 – ₹50 lakhs

Medium-scale

₹50 lakhs – ₹1.5 crores

Large-scale (injections, APIs)

₹2 crores and above

These figures cover:

  • Land & building (owned/rented)

  • Machinery & equipment

  • Staff salaries

  • Licensing & documentation

  • Raw materials & utilities


7. Machinery and Equipment

Machinery varies based on the type of formulation. Some examples:

  • Tablet Manufacturing: Tablet compression machine, coating pan, granulator

  • Liquid Syrups: Mixing tanks, filtration, bottling, labeling machines

  • Capsules: Capsule filling and polishing machines

  • Packaging: Blister packing, strip packing, shrink wrapping

Buy from GMP-certified equipment manufacturers.


8. Quality Control & Compliance

Set up Quality Control (QC) and Quality Assurance (QA) departments. Implement SOPs (Standard Operating Procedures) and documentation systems including:

  • Batch Manufacturing Records (BMR)

  • Batch Packing Records (BPR)

  • Stability studies

  • In-house testing labs

  • Raw material testing protocols

You must adhere to Schedule M guidelines and subject yourself to regular audits by Drug Inspectors.


9. Product Registration & Marketing

Once the unit is licensed:

  • Register each product with Drug Controller

  • Design branding, packaging, and labeling

  • Apply for barcodes if exporting

  • Market your products via:

    • PCD Pharma Franchise model

    • Direct medical representative network

    • Online B2B portals

    • Third-party manufacturing


10. Export Opportunities

India exports pharmaceuticals to over 200 countries, with top markets including the US, Africa,

and the EU. For exports:

  • Get Import Export Code (IEC) from DGFT

  • Comply with the receiving country’s regulatory bodies like USFDA, TGA, EUGMP, etc.

  • WHO-GMP and Certificate of Pharmaceutical Product (COPP) is mandatory

Exporting can significantly increase profit margins.


11. Government Support and Subsidies

The Indian government offers several schemes and benefits:

  • PLI Scheme for bulk drugs and APIs

  • Subsidies for plant setup in Pharma Parks (like Baddi, Hyderabad, Sikkim)

  • MSME Benefits: Tax exemptions, lower-interest loans, marketing support

  • Technology Upgradation Fund (TUF)


12. Challenges to Watch For

  • Regulatory compliance burden

  • Skilled manpower shortage

  • High initial investment

  • Product pricing pressure

  • Constant need for R&D

However, with a solid foundation and expert guidance, these can be managed efficiently.

Bottom Line

Starting a pharmaceutical manufacturing unit in India is a promising business opportunity that combines profitability with social impact. The process involves regulatory know-how, significant planning, and technical infrastructure — but the growing demand for quality healthcare makes it a venture worth investing in. Whether you’re entering as a first-time entrepreneur or an industry expert, proper execution is key.

For those looking to outsource or enter pharma manufacturing without setting up from scratch, working with a reputed third-party manufacturer is a smart choice. EthixElite Lifesciences Private Limited is a trusted name in the Indian pharmaceutical landscape, offering WHO-GMP certified manufacturing services, quality-assured product development, and PCD pharma franchise opportunities. Whether you're planning your own brand or exploring contract manufacturing, EthixElite can be your partner in growth.

 
 
 

Comments


bottom of page